CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Adamas Pharmaceuticals Inc  (ADMS)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

ADMS's Revenue Growth by Quarter and Year

Adamas Pharmaceuticals Inc's Revenue results by quarter and year




ADMS Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - 0.57 0.04 0.52
III Quarter September - - 0.14 0.77
II Quarter June 7.57 - 0.22 0.40
I Quarter March 2.55 - 0.18 0.23
FY   10.12 0.57 0.58 1.92



ADMS Revenue second quarter 2018 Y/Y Growth Comment
Adamas Pharmaceuticals Inc in the second quarter achieved Revenue of $ 7.57 millions compare to recorded in same quarter a year ago.

Among companies who have reported second quarter results in the Major Pharmaceutical Preparations industry only one Company has achieved higher year on year Revenue results in the second quarter. While Adamas Pharmaceuticals Inc' s Revenue no change of % ranks overall at the positon no. 5 in the second quarter.




ADMS Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - 1325 % -92.31 % -98.28 %
III Quarter September - - -81.82 % 250 %
II Quarter June - - -45 % -98.41 %
I Quarter March - - -21.74 % 27.78 %
FY   - -1.72 % -69.79 % -

Financial Statements
Adamas Pharmaceuticals Inc's second quarter 2018 Revenue $ 7.57 millions ADMS's Income Statement
Adamas Pharmaceuticals Inc's second quarter 2017 Revenue $ 0.00 millions Quarterly ADMS's Income Statement
New: More ADMS's historic Revenue Growth >>


ADMS Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - -71.43 % -32.47 %
III Quarter September - - -36.36 % 92.5 %
II Quarter June 196.67 % - 22.22 % 73.91 %
I Quarter March 347.37 % - -65.38 % -99.24 %
FY (Year on Year)   - -1.72 % -69.79 % -




Revenue second quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #2
Overall #5
Revenue Y/Y Growth Statistics
High Average Low
378150 % 29164.15 % -100 %
(Jun 30 2018)   (Mar 31 2017)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018
You need to upgrade your Flash Player

Adamas Pharmaceuticals Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #9
Overall #22
Revenue Q/Q Growth Statistics
High Average Low
56700 % 5316.84 % -100 %
(Dec 31 2017)  


ADMS's II. Quarter Q/Q Revenue Comment
Adamas Pharmaceuticals Inc achieved in the II. Quarter 2018 below company average Revenue doubling of 196.67% quarter on quarter, to $ 7.57 millions.

II. Quarter 2018 Adamas Pharmaceuticals Inc's Revenue Q/Q growth seem to be a mixed bag, albeit lower than the ordinary growth of 5316.84 %, yet it presents absolute recovery measured to the % in the same quarter a year ago Aadhya Das , an industry contributor wrote.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Adamas Pharmaceuticals Inc's Revenue growth quarter on quarter, overall rank is 22.


Adamas Pharmaceuticals Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
12 Months Ending
(Jun 30 2017)
Cumulative Revenue 12 Months Ending $ 10.69 $ 3.12 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) 242.09 % - - - -
Seq. Revenue Growth (TTM) Overall Ranking # 3 # 2 # 0 # 0 # 0




Cumulative Revenue growth Comment


Adamas Pharmaceuticals Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
242.09 %
-2.11 %
-93.95 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
-61.06 %
-85.95 %
-96.66 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 2
S&P 500 # 3


You need to upgrade your Flash Player




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ADMS's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ADMS's Competitors
Revenue Growth for Adamas Pharmaceuticals Inc's Suppliers
Revenue Growth for ADMS's Customers

You may also want to know
ADMS's Annual Growth Rates ADMS's Profitability Ratios ADMS's Asset Turnover Ratio ADMS's Dividend Growth
ADMS's Roe ADMS's Valuation Ratios ADMS's Financial Strength Ratios ADMS's Dividend Payout Ratio
ADMS's Roa ADMS's Inventory Turnover Ratio ADMS's Growth Rates ADMS's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Jun 30 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2018
United Therapeutics Corp -0.02 %$ -0.022 millions
Tg Therapeutics, Inc. -0.25 %$ -0.249 millions
Pacific Health Care Organization Inc -0.84 %$ -0.843 millions
Prestige Brands Holdings, Inc. -1.01 %$ -1.011 millions
Jaguar Health, Inc. -1.41 %$ -1.414 millions
Regenerx Biopharmaceuticals Inc -1.59 %$ -1.590 millions
Capital Senior Living Corp -1.79 %$ -1.791 millions
Vycor Medical Inc -1.96 %$ -1.956 millions
Five Star Senior Living Inc. -1.98 %$ -1.979 millions
Rti Surgical, Inc. -1.99 %$ -1.990 millions
Retractable Technologies Inc -2.24 %$ -2.238 millions
Icad Inc -2.26 %$ -2.262 millions
Hca Healthcare, Inc. -2.35 %$ -2.346 millions
Brookdale Senior Living Inc. -2.64 %$ -2.636 millions
Vitality Biopharma, Inc. -2.64 %$ -2.644 millions
Biolase, Inc -3.63 %$ -3.631 millions
Milestone Scientific Inc. -3.77 %$ -3.774 millions
Akorn Inc -4.12 %$ -4.116 millions
Radnet, Inc. -4.61 %$ -4.608 millions
Bausch Health Companies Inc. -4.70 %$ -4.702 millions
Aratana Therapeutics, Inc. -4.85 %$ -4.847 millions
Vet Online Supply Inc -5.28 %$ -5.278 millions
Corium International, Inc. -5.41 %$ -5.414 millions
Amag Pharmaceuticals Inc. -7.66 %$ -7.664 millions
Endologix Inc -7.86 %$ -7.859 millions
Windtree Therapeutics Inc -8.37 %$ -8.370 millions
Tearlab Corp -8.57 %$ -8.569 millions
Anika Therapeutics, Inc. -8.71 %$ -8.708 millions
Teligent, Inc. -9.00 %$ -9.002 millions
Digirad Corp -9.08 %$ -9.085 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HIBB's Profile

Stock Price

HIBB's Financials

Business Description

Fundamentals

Charts & Quotes

HIBB's News

Suppliers

HIBB's Competitors

Customers & Markets

Economic Indicators

HIBB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071